ArticleSystematic reviews2026
Female genital schistosomiasis-related infertility and gynecological manifestations among women living in countries endemic for urogenital schistosomiasis in Africa: systematic review and meta-analysis protocol.
Article in Systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionFemale genital schistosomiasis (FGS), affecting over 56 million women and girls, is a neglected tropical disease with substantial public health implications. Existing evidence on its impact on reproductive health, particularly infertility, is limited and, in most cases, inconclusive. This systematic review aims to gather evidence on the magnitude of FGS-related gynecological manifestations and infertility among females of reproductive age living in countries across Africa.
methodsWe will search PubMed, CINAHL, LILACS, Google Scholar, Web of Science, and African Journals Online (AJOL) from inception to 31st August 2026, without language restrictions, using terms such as "female genital schistosomiasis", "FGS", and "infertility" together with all applicable alternative terms nested with the appropriate Boolean operators. We will also search gray sources such as conference proceedings, dissertations, WHO databases, and preprint repositories for studies. The reference lists of relevant studies will be hand-searched for additional studies potentially missed by our searches. Retrieved studies will be collated and deduplicated using EndNote and exported to Rayyan QCRI for screening. At least two reviewers will independently select studies, extract data, and assess the quality of the included studies using validated tools, resolving disagreements through discussion. We will use pooled proportions for non-comparative studies and odds ratios or risk ratios for comparative studies reporting categorical data, while mean and mean difference (MD) will be used to summarize continuous data. All estimates will be reported with their corresponding 95% confidence intervals (CIs). Random-effects or fixed-effect meta-analysis models will be employed, depending on the extent of heterogeneity between studies. The heterogeneity will be assessed graphically for overlapping CIs and statistically using the I SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42023449271.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.